Home » Business » Fresenius Kabi expands IV drug business in Latin America with buy of Novafarma – The Pharma Letter

Fresenius Kabi expands IV drug business in Latin America with buy of Novafarma – The Pharma Letter

Fresenius Kabi expands IV drug business in Latin America with buy of Novafarma
The Pharma Letter
“With this acquisition, we are building on our long-term market presence in Brazil and establishing a strong hub for the further expansion of our generic drug business in the Latin American region,” said Mats Henriksson, chief executive of Fresenius Kabi.